MarketInOut Stock Screener Log In | Sign Up

Ind-Swift Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Ind-Swift Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization28,965 mln
Float40.14 mln
Earnings Date10/29/2026

EPS

6.69
Stretched

P / E

56.05
Richly valued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.18
Caution advised

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.01
Debt-free

Business Description

Ind-Swift Laboratories Limited is an India-based pharmaceutical company founded in 1995 that produces and sells active drug ingredients, intermediates, and finished medicines to customers both domestically and abroad. The company serves a wide range of medical needs, covering conditions such as heart disease, diabetes, cancer, infections, and neurological disorders, among many others. In addition to its core product line, Ind-Swift also offers contract research and manufacturing services, supporting other businesses in developing and producing pharmaceutical compounds.

Key Fundamentals

EPS6.69
P/E56.05
ROE4.44
RPS76.42
ROIC2.25
ROA3.65
Interest Cover8.22
EBITDA, mln1,062
EV / EBITDA29.77
EV / EBIT42.34
Revenue, mln6,647
EV / Revenue4.75

Quote Details

Last 375.00
Change 38.6 (11.47%)
Open 332.90
Volume 60,848
Turnover 22,818,000
Average Volume 37,872

Financial Ratios

Pre-Tax Profit Margin11
Current Ratio3.80
Price / Book2.43
Price / Tangible Book2.47
Debt / Equity0.01
Price / Sales4.95
PEG Ratio0.96

Financial Strength

Altman Z-Score7.93
Piotroski F-Score 4 / 9
Beneish M-Score-2.18
Price to Intrinsic Value8.43
Price to Graham Number2.82
Shiller PE Ratio28.90

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.4% 95 / 100   
1 Month -6.68% 51 / 100   
2 Months 59.57% 97 / 100   
6 Months 175% 99 / 100   
1 Year 257% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog